SEROPREVALENCE OF HEPATITIS A VIRUS IN EGYPTIAN CHILDREN AND ADOLESCENTS WITH HEMOPHILIA A: SAFETY AND IMMUNOGENICITY OF SUBCUTANEOUS HEPATITIS A VACCINE

被引:0
|
作者
Tantawy, A. [1 ]
AlGohary, I. [1 ]
Ghani, S. Abdel [1 ]
El Hadary, S. [1 ]
机构
[1] Ain Shams Univ, Fac Med, Cairo, Egypt
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
0709
引用
收藏
页码:297 / 297
页数:1
相关论文
共 50 条
  • [21] Seroprevalence of hepatitis A virus antibodies among children and adolescents living in Northern Thailand: an implication for hepatitis A immunization
    Kunanitthaworn, Natchaya
    Mueangmo, Oramai
    Saheng, Jutamad
    Wongjak, Worawan
    Lertsiriladakul, Tanin
    Chaito, Tanachot
    Nantarat, Pasawat
    Sudjaritruk, Tavitiya
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [22] Seroprevalence of hepatitis A virus antibodies among children and adolescents living in Northern Thailand: an implication for hepatitis A immunization
    Natchaya Kunanitthaworn
    Oramai Mueangmo
    Jutamad Saheng
    Worawan Wongjak
    Tanin Lertsiriladakul
    Tanachot Chaito
    Pasawat Nantarat
    Tavitiya Sudjaritruk
    Scientific Reports, 13
  • [23] IMMUNOGENICITY OF INACTIVATED HEPATITIS-A VACCINE IN CHILDREN
    LEE, SD
    LO, KJ
    CHAN, CY
    YU, MY
    WANG, YJ
    SAFARY, A
    GASTROENTEROLOGY, 1993, 104 (04) : 1129 - 1132
  • [24] Immunogenicity of Hepatitis A Vaccine in Children With Celiac Disease
    Sari, Sinan
    Dalgic, Buket
    Basturk, Bilkay
    Gonen, Sevim
    Soylemezoglu, Oguz
    JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION, 2011, 53 (05): : 532 - 535
  • [25] Immunogenicity and safety of a virosomal hepatitis A vaccine (Epaxal®) in healthy toddlers and children in Chile
    Riedemann, S
    Reinhardt, G
    Ibarra, H
    Frösner, GG
    ACTA PAEDIATRICA, 2004, 93 (03) : 412 - 414
  • [26] COMPARATIVE IMMUNOGENICITY AND SAFETY OF 2 DIFFERENT DOSES OF HEPATITIS-B VACCINE IN ADOLESCENTS
    ZELDIS, J
    HEPATOLOGY, 1991, 14 (04) : A224 - A224
  • [27] An open study of subcutaneous administration of inactivated hepatitis A vaccine (VAQTA®) in adults:: safety, tolerability, and immunogenicity
    Linglöf, T
    van Hattum, J
    Kaplan, KM
    Corrigan, J
    Duval, I
    Jensen, E
    Kuter, B
    VACCINE, 2001, 19 (28-29) : 3968 - 3971
  • [28] COMPARATIVE IMMUNOGENICITY AND SAFETY OF 2 DIFFERENT DOSES OF HEPATITIS-B VACCINE IN ADOLESCENTS
    AREIAS, J
    LOPES, I
    HEPATOLOGY, 1992, 16 (04) : A195 - A195
  • [29] Safety and immunogenicity of a combined hepatitis A and hepatitis B vaccine in young healthy adults
    LerouxRoels, G
    Moreau, E
    Desombere, I
    Safary, A
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 1996, 31 (10) : 1027 - 1031
  • [30] IMMUNOGENICITY, SAFETY AND TOLERABILITY OF VARYING DOSES AND REGIMENS OF INACTIVATED HEPATITIS-A VIRUS-VACCINE IN NAVAJO CHILDREN
    NEWCOMER, W
    RIVIN, B
    REID, R
    MOULTON, LH
    WOLFF, M
    CROLL, J
    JOHNSON, C
    BROWN, L
    NALIN, D
    SANTOSHAM, M
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1994, 13 (07) : 640 - 642